EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Molecular and structural insights into the 5‐HT 2C receptor as a therapeutic target for substance use disorders

Maleesha Ubhayarathna, Christopher J Langmead iD, Natalie A Diepenhorst, Gregory D Stewart iD

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16233 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Maleesha Ubhayarathna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Biology and Neuroscience & Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Par…. Hauptthemen laut MEDLINE: Receptor, Serotonin, 5-HT2C, Substance-Related Disorders. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Substance use disorder (SUD) is a chronic condition, with maintained abuse of a substance leading to physiological and psychological alterations and often changes in cognitive and social behaviours. Current therapies include psychotherapy coupled with medication; however, high relapse rates reveal the shortcomings of these therapies. The signalling, expression profile, and neurological function of the serotonin 2C receptor (5‐HT 2C receptor) make it a candidate of interest for the treatment of SUD. Recently, psychedelics, which broadly act at 5‐HT 2 receptors, have indicated potential for the treatment of SUD, implicating the 5‐HT 2C receptor. The modern psychedelic movement has rekindled interest in the 5‐HT 2C receptor, resulting in many new studies, especially structural analyses. This review explores the structural, molecular and cellular mechanisms governing 5‐HT 2C receptor function in the context of SUD. This provides the basis of the preclinical and clinical evidence for their role in SUD and highlights the potential for future exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Serotonin, 5-HT2CSubstance-Related DisordersHumansAnimalsSerotonin 5-HT2 Receptor AgonistsHallucinogens

Stichwörter der Autor:innen

5‐HT5‐HT2C receptorGPCRSUDscell signallingdrug discovery

Substanzen

Receptor, Serotonin, 5-HT2CSerotonin 5-HT2 Receptor AgonistsHallucinogens

Autor:innen und Institutionen

  • Drug Discovery Biology and Neuroscience & Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.
  • ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.
  • Neuromedicines Discovery Centre, Monash University, Parkville, Australia.

ORCID-Profile: Christopher J Langmead, Gregory D Stewart

Zitieren

APA

Ubhayarathna, M., Langmead, C. J., Diepenhorst, N. A., & Stewart, G. D. (2024). Molecular and structural insights into the 5‐HT 2C receptor as a therapeutic target for substance use disorders. British Journal of Pharmacology. https://doi.org/10.1111/bph.16233

Vancouver

Ubhayarathna M, Langmead CJ, Diepenhorst NA, Stewart GD. Molecular and structural insights into the 5‐HT 2C receptor as a therapeutic target for substance use disorders. British Journal of Pharmacology. 2024. doi:10.1111/bph.16233

BibTeX
@article{Ubhayarathna2024,
  author = {Ubhayarathna, Maleesha and Langmead, Christopher J and Diepenhorst, Natalie A and Stewart, Gregory D},
  title = {Molecular and structural insights into the 5‐HT 2C receptor as a therapeutic target for substance use disorders},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16233}
}
Kostenlos starten →